Phase I Clinical Trial To Test Combination Of Two HIV Vaccine Candidates Starts In London
Thursday, November 27, 2008 - 09:22
in Health & Medicine
Researchers have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates. The news follows promising results for one of the two vaccine candidates to be tested, the MVA-based TBC-M4, which in a recent phase I trial generated modest immune responses in all volunteers who received the highest dose.
Read the whole article on Science Daily
More from Science Daily
Related
- India continues to progress in AIDS vaccine development effortsMon, 18 Aug 2008, 0:22:02 EDT
- IAVI statement in response to NIAID decision not to move forward with PAVE 100 HIV Vaccine TrialThu, 17 Jul 2008, 12:14:46 EDT
- Novel tuberculosis vaccine in Germany in clinical phaseThu, 11 Sep 2008, 11:16:59 EDT
- NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidatesWed, 22 Jul 2009, 13:46:33 EDT
- Promising trials of malaria vaccine lead to calls for Phase 3 developmentMon, 8 Dec 2008, 12:32:14 EST